Company Information

CIN
Status
Date of Incorporation
06 November 2018
State / ROC
/ ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
Paid Up Capital
254,564,956
Authorised Capital
400,000,000

Directors

Hanumantha Rao Kokkonda
Hanumantha Rao Kokkonda
Director/Designated Partner
almost 2 years ago
Venkata Ramudu Jasthi
Venkata Ramudu Jasthi
Director/Designated Partner
almost 2 years ago
Pravin Udhyavara Bhadya Rao
Pravin Udhyavara Bhadya Rao
Director/Designated Partner
about 2 years ago
Shweta Jalan
Shweta Jalan
Director/Designated Partner
about 2 years ago
Sudhir Kumar Singh
Sudhir Kumar Singh
Director/Designated Partner
about 2 years ago
Pankaj Bhuneshwar Patwari
Pankaj Bhuneshwar Patwari
Director/Designated Partner
about 2 years ago
Matangi Gowrishankar
Matangi Gowrishankar
Director/Designated Partner
about 2 years ago
Vinod Rao
Vinod Rao
Director/Designated Partner
about 2 years ago
Venkatanaga Kali Vara Prasada Raju Vetukuri
Venkatanaga Kali Vara Prasada Raju Vetukuri
Director/Designated Partner
about 2 years ago
Annaswamy Vaidheesh
Annaswamy Vaidheesh
Director/Designated Partner
about 2 years ago
Kumarapuram Gopalakrishnan Ananthakrishnan
Kumarapuram Gopalakrishnan Ananthakrishnan
Director/Designated Partner
about 2 years ago
Venkateswarlu Jasti
Venkateswarlu Jasti
Director/Designated Partner
over 2 years ago
Deepanwita Chattopadhyay .
Deepanwita Chattopadhyay .
Director/Designated Partner
over 2 years ago
Kukudala Ravi
Kukudala Ravi
Deputy Nodal Officer
over 3 years ago
Subbarao Jasti
Subbarao Jasti
Beneficial Owner
over 5 years ago
Subba Rao Parupalli
Subba Rao Parupalli
Manager/Secretary
almost 6 years ago
Govinda Prasad Dasu
Govinda Prasad Dasu
Director/Designated Partner
about 6 years ago
Sunder Venkatraman
Sunder Venkatraman
Director/Designated Partner
about 7 years ago

Past Directors

Srivari Chandrasekhar
Srivari Chandrasekhar
Director
about 6 years ago

Patents

The present invention describes substituted 3-aminoalkoxyindoles, as compounds of the general formula (I), its stereoismers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bioactive metabolites and any s...

Glycopyrrolate Oral Film And It’s Process

ABSTRACT GLYCOPYRROLATE ORAL FILM AND IT’S PROCESS The present invention relates to novel oral film composition comprising anticholinergic agent as active ingredient and pharmaceutically acceptable excipients. The present invention specifically relates to novel oral film composition comprising Glycopyrronium salts...

Charges

29 December 2020
Others
0
05 November 2020
State Bank Of India
0